"Transparent" Liver

Research Article

J Hepat Res. 2014;1(1): 1001.

"Transparent" Liver

Fanpu Ji1,2, Hongan Xue2, Weili Min3, Hong Deng2, and Zongfang Li1*

1Department of General Surgery, Xi'an Jiaotong University, China

2Department of Infectious Diseases, Xi'an Jiaotong University, China

3Department of Oncology, Xi'an Jiaotong University, China

*Corresponding author: Li ZF, Department of General Surgery, the Second Affiliated Hospital, College of Medicine, Xi'an Jiaotong University, 157 Xi Wu Road, Xi'an 710004, Shaanxi Province, PR. China

Received: July 11, 2014; Accepted: July 20, 2014; Published: July 23, 2014


Non-alcoholic steatohepatitis; Tamoxifen; Adverse drug reaction; Breast cancer

Clinical Image

A 38-year-old female with estrogen receptor-positive breast cancer came to our hospital for routine evaluation. She had undergone mastectomy 18 months ago and received oral tamoxifen (20 mg/day) as adjuvant endocrine therapy for 17 months. She had no diabetes mellitus, hypertension, hyperlipidemia or HBV/HCV infection history, and no drinking habit. Her body mass index was 22.5, and liver function was normal before tamoxifen therapy. Laboratory tests revealed an elevated alanine aminotransferase (ALT) (72 U/L) and glutamyltransferase (115 U/L) (both normal up to 40 U/L); the cholesterol, triglyceride, and aspartate aminotransferase were within normal range. Unenhanced abdominal computed tomography (CT) scan showed diffused liver parenchymal density reduction and intrahepatic vascular density was relatively high with a liver/spleen ratio of -0.13 (Figure 1A, 1B). A diagnosis of tamoxifenassociated severe non-alcoholic steatohepatitis (NASH) was made, although absence of histopathological confirmation. Tamoxifen was discontinued, and letrozole (2.5mg/day) was prescribed. Her aminotransferase levels returned to normal limits 6 months subsequently. A repeat CT one year later showed hepatic steatosis remission with liver/spleen ratio of 1.0. She continued to receive letrozole and remains well after 12 months of follow-up.

Citation: Ji F, Xue H, Min W, Deng H and Li Z. "Transparent" Liver. J Hepat Res. 2014;1(1): 1001. ISSN:2381-9057